Patent · US Active

Medicament for use in treating fatty liver, hepatitis and cirrhosis

US11000569B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 20, 2017
Grant dateMay 11, 2021
Priority date
Expiry dateJan 20, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A medicament for use in treating fatty liver, hepatitis and cirrhosis, the medicament includes a marine algal glycoprotein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.